Authors:
DAMMACCO F
SILVESTRIS F
CASTOLDI GL
GRASSI B
BERNASCONI C
NADALI G
PERONA G
DELAURENZI A
TORELLI U
ASCARI E
FERRINI PLR
CALIGARISCAPPIO F
PILERI A
RESEGOTTI L
Citation: F. Dammacco et al., THE EFFECTIVENESS AND TOLERABILITY OF EPOETIN-ALPHA IN PATIENTS WITH MULTIPLE-MYELOMA REFRACTORY TO CHEMOTHERAPY, International journal of clinical & laboratory research, 28(2), 1998, pp. 127-134
Authors:
CORATO A
NADALI G
ROSSI B
AMBROSETTI A
LAMBIASE A
PIZZOLO G
PERONA G
Citation: A. Corato et al., TRANSPLANTATION POTENTIAL OF HEMATOPOIETIC-CELLS COLLECTED FROM WHOLE-BLOOD OF PATIENTS TREATED WITH VACOP-B CHEMOTHERAPY PLUS FILGRASTIM (R-METHUG-CSF), Experimental hematology, 26(8), 1998, pp. 373-373
Authors:
VINANTE F
RIGO A
TECCHIO C
MOROSATO L
NADALI G
RICETTI MM
KRAMPERA M
ZANOLIN E
LOCATELLI F
GALLATI H
CHILOSI M
PIZZOLO G
Citation: F. Vinante et al., SERUM LEVELS OF P55 AND P75 SOLUBLE TNF RECEPTORS IN ADULT ACUTE-LEUKEMIA AT DIAGNOSIS - CORRELATION WITH CLINICAL AND BIOLOGICAL FEATURES AND OUTCOME, British Journal of Haematology, 102(4), 1998, pp. 1025-1034
Authors:
NADALI G
TAVECCHIA L
ZANOLIN E
BONFANTE V
VIVIANI S
CAMERINI E
MUSTO P
DIRENZO N
CAROTENUTO M
CHILOSI M
KRAMPERA M
PIZZOLO G
Citation: G. Nadali et al., SERUM LEVEL OF THE SOLUBLE FORM OF THE CD30 MOLECULE IDENTIFIES PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 91(8), 1998, pp. 3011-3016
Authors:
PIZZOLO G
VINANTE F
NADALI G
KRAMPERA M
MOROSATO L
CHILOSI M
Citation: G. Pizzolo et al., HIGH SERUM LEVEL OF SOLUBLE CD30 IN ACUTE PRIMARY HIV-1 INFECTION, Clinical and experimental immunology, 108(2), 1997, pp. 251-253
Authors:
CORATO A
PERANDIN F
TAVECCHIA L
VINCENZI C
ROSSI B
AMBROSETTI A
LAMBIASE A
PIZZOLO G
PERONA G
NADALI G
Citation: A. Corato et al., STANDARD-DOSE CHEMOTHERAPY PLUS FILGRASTIM (R-METHUG-CSF) FOR AUTOLOGOUS MOBILIZATION IN PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 4206-4206
Authors:
NADALI G
TAVECCHIA L
ZANOLIN E
BONFANTE V
MUSTO P
CHILOSI M
MOROSATO L
PIZZOLO G
Citation: G. Nadali et al., HIGH SERUM LEVELS OF SOLUBLE CD30 RECOGNIZE AT DIAGNOSIS PATIENTS WITH HODGKINS-DISEASE AT HIGH-RISK OF UNFAVORABLE OUTCOME, Blood, 90(10), 1997, pp. 1739-1739
Authors:
DEWYNTER EA
NADALI G
COUTINHO LH
TESTA NG
Citation: Ea. Dewynter et al., EXTENSIVE AMPLIFICATION OF SINGLE CELLS FROM CD34(-CORD BLOOD AND IDENTIFICATION OF LONG-TERM CULTURE-INITIATING CELLS PRESENT IN 2 SUBSETS() SUBPOPULATIONS IN UMBILICAL), Stem cells, 14(5), 1996, pp. 566-576
Authors:
TODESCHINI G
TECCHIO C
MENEGHINI V
PIZZOLO G
KRAMPERA M
AMBROSETTI A
VENERI D
NADALI G
FRANCHINI M
PERONA G
Citation: G. Todeschini et al., ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN ELDERLY PATIENTS RECEIVING INTENSIVE TREATMENT - EXPERIENCE IN 26 CONSECUTIVE PATIENTS, Blood, 88(10), 1996, pp. 3407-3407
Authors:
CHILOSI M
DOGLIONI C
MAGALINI A
INGHIRAMI G
KRAMPERA M
NADALI G
RAHAL D
PEDRON S
BENEDETTI A
SCARDONI M
MACRI E
LESTANI M
MENESTRINA F
PIZZOLO G
SCARPA A
Citation: M. Chilosi et al., P21 WAF1 CYCLIN-KINASE INHIBITOR EXPRESSION IN NON-HODGKINS-LYMPHOMAS- A POTENTIAL MARKER OF P53 TUMOR-SUPPRESSOR GENE-FUNCTION/, Blood, 88(10), 1996, pp. 4012-4020
Authors:
VINANTE F
VASSANELLI A
ZANOTTI R
NADALI G
KRAMPERA M
VINCENZI C
MOROSATO L
CHILOSI M
PIZZOLO G
Citation: F. Vinante et al., CIRCULATING LEVELS OF SOLUBLE CD23 REFLECT CLINICAL AND BIOLOGICAL FEATURES OF LEUKEMIC B-CELL CHRONIC LYMPHOPROLIFERATIVE DISORDERS, International journal of clinical & laboratory research, 25(4), 1995, pp. 189-194
Citation: G. Nadali et al., CD34 CELL-SEPARATION - FROM BASIC RESEARCH TO CLINICAL-APPLICATIONS, International journal of clinical & laboratory research, 25(3), 1995, pp. 121-127
Authors:
NADALI G
VINANTE F
RIGO A
TECCHIO C
MOROSATO L
ZANOLIN E
PERONA G
CHILOSI M
PIZZOLO G
Citation: G. Nadali et al., CORRELATION BETWEEN CLINICAL-FEATURES AND CIRCULATING LEVELS OF SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN HODGKINS-DISEASE, International journal of clinical & laboratory research, 25(2), 1995, pp. 84-87
Authors:
PIZZOLO G
VINCENZI C
VINANTE F
NADALI G
JANOSSY G
Citation: G. Pizzolo et al., ORTHO PERMEAFIX(TM) FIXATION IS NOT SUITABLE FOR THE FLOW CYTOMETRIC DETECTION OF NUCLEAR TERMINAL TRANSFERASE IN ACUTE MYLOID LEUKEMIA-CELLS - REPLY, Leukemia, 9(1), 1995, pp. 228-228
Authors:
NADALI G
VINANTE F
STEIN H
TODESCHINI G
TECCHIO C
MOROSATO L
CHILOSI M
MENESTRINA F
KINNEY MC
GREER JP
LATZA U
PERONA G
PIZZOLO G
Citation: G. Nadali et al., SERUM LEVELS OF THE SOLUBLE FORM OF CD30 MOLECULE AS A TUMOR-MARKER IN CD30(-CELL LYMPHOMA() ANAPLASTIC LARGE), Journal of clinical oncology, 13(6), 1995, pp. 1355-1360
Authors:
AMBROSETTI A
CORATO A
ZANOTTI R
NADALI G
TODESCHINI G
MENEGHINI V
RICETTI M
BENEDETTI F
PIZZOLO G
Citation: A. Ambrosetti et al., HAIRY-CELL LEUKEMIA - SOLUBLE CD25 IN MONITORING THE RESPONSE TO TREATMENT WITH 2-CDA, Blood, 86(10), 1995, pp. 3296-3296
Authors:
PIZZOLO G
VINCENZI C
NADALI G
VENERI D
VINANTE F
CHILOSI M
BASSO G
CONNELLY MC
JANOSSY G
Citation: G. Pizzolo et al., DETECTION OF MEMBRANE AND INTRACELLULAR ANTIGENS BY FLOW-CYTOMETRY FOLLOWING ORTHO PERMEAFIX(TM) FIXATION, Leukemia, 8(4), 1994, pp. 672-676
Authors:
TODESCHINI G
MENEGHINI V
PIZZOLO G
CASSIBBA V
AMBROSETTI A
VENERI D
NADALI G
ZANOTTI R
TECCHIO C
PERONA G
Citation: G. Todeschini et al., RELATIONSHIP BETWEEN DAUNORUBICIN DOSAGE DELIVERED DURING INDUCTION THERAPY AND OUTCOME IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 8(3), 1994, pp. 376-381
Authors:
NADALI G
VINANTE F
AMBROSETTI A
TODESCHINI G
VENERI D
ZANOTTI R
MENEGHINI V
RICETTI MM
BENEDETTI F
VASSANELLI A
PERONA G
CHILOSI M
MENESTRINA F
FIACCHINI M
STEIN H
PIZZOLO G
Citation: G. Nadali et al., SERUM LEVELS OF SOLUBLE CD30 ARE ELEVATED IN THE MAJORITY OF UNTREATED PATIENTS WITH HODGKINS-DISEASE AND CORRELATE WITH CLINICAL-FEATURES AND PROGNOSIS, Journal of clinical oncology, 12(4), 1994, pp. 793-797
Authors:
VINANTE F
MOROSATO L
SIVIERO F
NADALI G
RIGO A
VENERI D
DESABATA D
VINCENZI C
CHILOSI M
SEMENZATO G
PIZZOLO G
Citation: F. Vinante et al., SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS, Haematologica, 79(5), 1994, pp. 413-419
Authors:
VINANTE F
MOROSATO L
SIVIERO F
NADALI G
RIGO A
VENERI D
DESABATA D
VINCENZI C
CHILOSI M
SEMENZATO G
PIZZOLO G
Citation: F. Vinante et al., SOLUBLE FORMS OF P55-IL-2R-ALPHA, CD8, AND CD30 MOLECULES AS MARKERS OF LYMPHOID-CELL ACTIVATION IN INFECTIOUS-MONONUCLEOSIS, Haematologica, 79(5), 1994, pp. 413-419
Authors:
NADALI G
VINANTE F
MOROSATO L
RICETTI MM
TECCHIO C
PIZZOLO G
Citation: G. Nadali et al., CLINICAL CORRELATIONS AND PROGNOSTIC-SIGNIFICANCE OF SERUM LEVELS OF SOLUBLE ICAM-1 IN HODGKINS-DISEASE, Experimental hematology, 22(8), 1994, pp. 735-735
Authors:
PIZZOLO G
VINANTE F
MOROSATO L
NADALI G
CHILOSI M
GANDINI G
SINICCO A
RAITERI R
SEMENZATO G
STEIN H
PERONA G
Citation: G. Pizzolo et al., HIGH SERUM LEVEL OF THE SOLUBLE FORM OF CD30 MOLECULE IN THE EARLY PHASE OF HIV-1 INFECTION AS AN INDEPENDENT PREDICTOR OF PROGRESSION TO AIDS, AIDS, 8(6), 1994, pp. 741-745